News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
471,737 Results
Type
Article (37611)
Company Profile (180)
Press Release (433946)
Section
Business (128640)
Career Advice (1087)
Deals (21691)
Drug Delivery (103)
Drug Development (46097)
Employer Resources (159)
FDA (11536)
Job Trends (11577)
News (213842)
Policy (22801)
Tag
Academia (2527)
Alliances (35323)
Alzheimer's disease (993)
Approvals (11526)
Artificial intelligence (145)
Bankruptcy (171)
Best Places to Work (9835)
Biotechnology (106)
Breast cancer (124)
Cancer (873)
Cardiovascular disease (88)
Career advice (963)
Cell therapy (184)
Clinical research (36507)
Collaboration (399)
Compensation (76)
COVID-19 (2349)
C-suite (97)
Data (974)
Diabetes (133)
Diagnostics (5338)
Drug pricing (92)
Earnings (39878)
Employer resources (136)
Events (82804)
Executive appointments (334)
FDA (12066)
Funding (358)
Gene therapy (133)
GLP-1 (471)
Government (4276)
Healthcare (16004)
Infectious disease (2440)
Inflammatory bowel disease (92)
Interviews (149)
IPO (9112)
Job creations (2127)
Job search strategy (858)
Layoffs (241)
Legal (4432)
Lung cancer (135)
Manufacturing (160)
Medical device (10038)
Medtech (10042)
Mergers & acquisitions (12741)
Metabolic disorders (374)
Neuroscience (1230)
NextGen Class of 2024 (5678)
Non-profit (4292)
Northern California (1183)
Obesity (225)
Opinion (144)
People (42809)
Phase I (11597)
Phase II (14734)
Phase III (12880)
Pipeline (340)
Postmarket research (1748)
Preclinical (4438)
Radiopharmaceuticals (168)
Rare diseases (195)
Real estate (4148)
Regulatory (15174)
Research institute (2190)
Resumes & cover letters (132)
Southern California (903)
Startups (2845)
United States (10947)
Vaccines (509)
Weight loss (152)
Date
Today (95)
Last 7 days (431)
Last 30 days (1759)
Last 365 days (25804)
2024 (25690)
2023 (29055)
2022 (38692)
2021 (42450)
2020 (42194)
2019 (37824)
2018 (28262)
2017 (21842)
2016 (22863)
2015 (25917)
2014 (19689)
2013 (16218)
2012 (17375)
2011 (17799)
2010 (16153)
Location
Africa (653)
Arizona (123)
Asia (26128)
Australia (4662)
California (2506)
Canada (1058)
China (214)
Colorado (135)
Connecticut (150)
Europe (59924)
Florida (376)
Georgia (117)
Illinois (313)
Indiana (210)
Kansas (76)
Maryland (477)
Massachusetts (2033)
Michigan (139)
Minnesota (193)
New Jersey (857)
New York (836)
North Carolina (584)
Northern California (1183)
Ohio (105)
Pennsylvania (674)
South America (866)
Southern California (903)
Texas (333)
Utah (100)
Washington State (307)
471,737 Results for "linear health sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Linear Health Sciences Reports Clinical, Commercial Milestones
Medical device company Linear Health Sciences today announced multiple clinical and commercial milestones for its Orchid SRV™ , a breakaway safety valve designed to improve the use of medical tubing in hospitals.
June 26, 2024
·
3 min read
BioMidwest
Linear Health Sciences Publishes Whitepaper Examining IV Dislodgement
Linear Health Sciences announced the publication of a new whitepaper on accidental dislodgement of IV catheter lines.
March 27, 2024
·
3 min read
Business
Linear Health Sciences Awarded IV Therapy Products - Needleless Connectors Agreement with Premier, Inc.
Linear Health Sciences has been awarded a national group purchasing agreement for the IV Therapy - Needleless Connectors category with Premier, Inc. Effective Jan. 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the Orchid SRV force-activated separation device.
January 10, 2024
·
2 min read
BioMidwest
Linear Health Sciences Announces Expanded Indication for Orchid Safety Release Valve
Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™ safety release valve.
October 17, 2023
·
4 min read
Business
Linear Health Sciences Advances Orchid SRV Commercialization With Two Key Hires
Medical device company Linear Health Sciences today advanced the commercialization of its Orchid SRV ™ tension-activated breakaway safety release valve, announcing the appointment of Rob Headley as vice president of sales and business development, and Jessica Czamanski as director of product and regulatory affairs.
June 27, 2023
·
3 min read
Policy
Linear Health Sciences Announces Expanded Pediatric Indication for Orchid Safety Release Valve
Medical device company Linear Health Sciences announced it received an expanded indication from the U.S. Food & Drug Administration for its Orchid SRV™, a tension-activated breakaway safety release valve designed to reduce the risk of IV catheter failure and replacement in hospitals.
May 16, 2023
·
3 min read
Business
Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device
Linear Health Sciences Receives Innovative Technology Contract from Vizient for Orchid SRV IV Safety Device.
November 8, 2022
·
4 min read
Deals
Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023
Seres Therapeutics, Inc., announced that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST capsules.
June 6, 2024
·
4 min read
Deals
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science
Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights.
June 6, 2024
·
5 min read
Policy
Women’s Health: Where Politics and Science Meet
On this episode of Denatured, Lori Ellis and guests discuss President Biden’s Executive Order on Advancing Women’s Health Research and Innovation and the outlook of investment in women’s health.
May 8, 2024
·
1 min read
1 of 47,174
Next